October 31, 2013
1 min read
Save

STAAR Surgical reports $17.1 million in total sales for third quarter

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Sales at STAAR Surgical totaled $17.1 million for the third quarter, an 7.8% increase from the same period in 2012, the company reported in a news release.

U.S. sales increased 7% and units grew 9%, with continuing signs that LASIK procedures are declining or flat.

For the 9-month period ending Sept. 27, sales increased to $53.3 million, a $6 million increase from the same period in 2012.

Third-quarter IOL sales totaled $5.3 million, a 12% decrease from the same period in 2012.

“The negative impact of foreign exchange was $809,000. Without the impact of foreign exchange, global IOL revenue would have increased 1% year over year,” the release said.

The Visian ICL accounted for 62.7% of total sales, compared with 57.4% of sales in the second quarter 2012. ICL sales totaled $10.7 million, an 18% increase from the second quarter 2012. This reflected a 15% increase in unit sales and a 2% price increase.

ICL revenues increased 9% in North America, 42% in Europe, 39% in the Middle East, 30% in Latin America and 10% in the Asia-Pacific region. Gains in the Europe-Middle East-Africa region were attributed to CentraFLOW technology with the ICL.

Revenues for the ICL increased 22% in China and decreased 5% in Japan.

Operating expenses totaled $11.9 million, an increase of 5% from the second quarter 2012. The increase stemmed from a manufacturing consolidation project.